Wide Leif, Eriksson Karin
Department of Medical Sciences, Uppsala University, Clinical Chemistry, University Hospital, Uppsala, Sweden.
J Endocr Soc. 2021 Feb 4;5(4):bvab006. doi: 10.1210/jendso/bvab006. eCollection 2021 Apr 1.
In severe primary hypothyroidism (sPH), the serum thyrotropin (TSH) levels are elevated with an increased degree of sialylation. The circulating TSH comprises 2 different TSH glycoforms: TSHdi with 2 and TSHtri with 3 N-glycans and methods have developed to determine their contents of anionic monosaccharides (AMS), that is, sialic acid (SA) and sulfonated N-acetylglactosamine (SU) residues.
Characterize N-glycosylation and glycan composition of circulating TSH molecules and determine the effects during levothyroxine treatment in patients with sPH.
Serum samples were obtained from 25 patients with sPH, from 159 euthyroid individuals, and from 12 women during treatment with levothyroxine for sPH. Degrees of N-glycosylation and concentrations of TSHdi and TSHtri as well as their contents of AMS, SA, and SU residues were determined.
The circulating TSH molecules in sPH patients had lower degrees of N-glycosylation, higher degrees of sialylation, and lower degrees of sulfonation than in euthyroid individuals. Levothyroxin restored sialylation and sulfonation of the glycans already at low free thyroxine (FT4) levels, while degree of N-glycosylation was not restored until the FT4 levels were normal.
The majority of TSH molecules in severe primary hypothyroidism were less N- glycosylated, more sialylated, and less sulfonated compared with euthyroid individuals. This glycan pattern favors a prolonged half-life in the circulation combined with lower in vitro biopotency at the target cells. During levothyroxine treatment of sPH patients, the sialylation and sulfonation of glycans were restored already at low FT4 levels, while N-glycosylation of TSH was not restored until the FT4 levels were normal.
在严重原发性甲状腺功能减退症(sPH)中,血清促甲状腺激素(TSH)水平升高且唾液酸化程度增加。循环中的TSH由两种不同的TSH糖型组成:具有2个N-聚糖的TSHdi和具有3个N-聚糖的TSHtri,并且已经开发出测定其阴离子单糖(AMS)含量的方法,即唾液酸(SA)和磺化N-乙酰半乳糖胺(SU)残基。
表征循环TSH分子的N-糖基化和聚糖组成,并确定左甲状腺素治疗对sPH患者的影响。
采集了25例sPH患者、159例甲状腺功能正常个体以及12例接受左甲状腺素治疗的sPH女性患者的血清样本。测定了N-糖基化程度、TSHdi和TSHtri的浓度以及它们的AMS、SA和SU残基含量。
与甲状腺功能正常个体相比,sPH患者循环中的TSH分子N-糖基化程度较低,唾液酸化程度较高,磺化程度较低。左甲状腺素在低游离甲状腺素(FT4)水平时就已恢复聚糖的唾液酸化和磺化,而N-糖基化程度直到FT4水平正常才恢复。
与甲状腺功能正常个体相比,严重原发性甲状腺功能减退症中的大多数TSH分子N-糖基化程度较低,唾液酸化程度较高,磺化程度较低。这种聚糖模式有利于延长循环半衰期并降低靶细胞的体外生物活性。在sPH患者接受左甲状腺素治疗期间,低FT4水平时聚糖的唾液酸化和磺化就已恢复,而TSH的N-糖基化直到FT4水平正常才恢复。